Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved in a...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospitalized pediatric drowning in Zhejiang, China (2010-2021): an epidemiological analysis.

BMC pediatrics·2026
Same author

Enhanced Yield of <i>GmJAG1</i>-Edited Soybeans Accompanied by Improved Function of the Rhizosphere Microbiome.

Plants (Basel, Switzerland)·2026
Same author

Astrocyte-derived IL-17A facilitates angiogenesis following ischemia-like injury via an IL-6-dependent STAT3-VEGF signaling cascade.

Behavioral and brain functions : BBF·2026
Same author

Sestrin2 Mitigates Neuronal Ferroptosis Following Subarachnoid Hemorrhage via Orchestration of the AMPK/PGC1α/Nrf2 Signaling Axis.

CNS neuroscience & therapeutics·2026
Same author

Copper homeostasis dysregulation and cuproptosis in respiratory diseases.

Experimental lung research·2026
Same author

Exogenous Methyl Jasmonate Promotes Triterpene Accumulation in Loquat Callus.

Foods (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 11, 2026

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Adiponectin and breast cancer.

Xiuping Chen1, Yitao Wang

  • 1Institute of Chinese Medical Sciences, University of Macau, Av. Padre Tomas Pereira S.J., Taipa, Macau, China. xpchen@umac.mo

Medical Oncology (Northwood, London, England)
|July 14, 2010
PubMed
Summary

Adiponectin, an obesity-related hormone, may influence breast cancer development. While studies show potential therapeutic benefits and tumor suppression, its exact role remains debated, requiring further research.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Adiponectin, a hormone from adipose tissue, possesses anti-inflammatory, anti-atherogenic, and anti-diabetic effects.
  • Emerging research indicates adiponectin's involvement in the development and progression of cancers, particularly obesity-related types.

Purpose of the Study:

  • To review the potential role of adiponectin in breast cancer, focusing on obesity- and endocrine-associated aspects.
  • To explore adiponectin's expression, epidemiological associations, and therapeutic potential in breast cancer models.

Main Methods:

  • Review of epidemiological studies on plasma adiponectin levels and breast cancer risk.
  • Analysis of adiponectin and receptor expression in breast cancer cell lines and tissues.
  • Examination of studies investigating exogenous adiponectin's effects in animal models.

More Related Videos

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
07:00

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation

Published on: August 23, 2018

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
05:34

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice

Published on: January 24, 2025

Related Experiment Videos

Last Updated: Jun 11, 2026

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
07:00

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation

Published on: August 23, 2018

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
05:34

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice

Published on: January 24, 2025

Main Results:

  • Epidemiological data suggests plasma adiponectin levels are a risk factor for breast cancer in post-menopausal women.
  • Adiponectin and its receptors are expressed in breast cancer cells and tumors.
  • Exogenous adiponectin demonstrated therapeutic potential in animal models by inhibiting proliferation, promoting apoptosis, regulating tumorigenic factors, and suppressing angiogenesis.

Conclusions:

  • Adiponectin signaling pathways may offer future drug targets for breast cancer.
  • Further research is necessary to definitively establish adiponectin's precise role in breast cancer, as findings are currently controversial.